Materias dentro de su búsqueda.
Mostrando 2,921 - 2,940 Resultados de 15,611 Para Buscar '"pancreatic cancer"', tiempo de consulta: 0.36s Limitar resultados
  1. 2921
    “…Long non-coding RNAs (lncRNAs) may play a role in oxidative stress by altering the tumor microenvironment, thereby affecting pancreatic cancer progression. There is currently limited information on oxidative stress-related lncRNAs as novel prognostic markers of pancreatic cancer. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Construction of a pancreatic cancer prediction model for oxidative stress-related lncRNA
  2. 2922
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Serum levels of iCAF‐derived osteoglycin predict favorable outcome in pancreatic cancer
  3. 2923
    “…Pancreatic cancer is one of the most malignant tumors with increased incidence rate. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective
  4. 2924
    “…Bioinformatics analyses of pancreatic cancer public datasets showed that glycogen phosphorylase L (PYGL) expression is elevated in quasimesenchymal PDAC (QM-PDAC) and positively associated with EMT. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    PYGL-mediated glucose metabolism reprogramming promotes EMT phenotype and metastasis of pancreatic cancer
  5. 2925
    “…BACKGROUND: One of the most diverse tumors is pancreatic cancer (PC), which makes predicting the prognosis challenging. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis
  6. 2926
    “…Evidence supporting the effectiveness of pancreatic cancer (PC) screening is scant. Most clinical studies concern small populations with short follow‐up durations. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The impact of pancreatic cancer screening on life expectancy: A systematic review of modeling studies
  7. 2927
    “…Finally, although the classical model of pancreatic cancer evolution emphasises the importance of early, homogenous somatic events as a key requirement for cancer development, ACT-Discover identified substantial heterogeneity of SCNAs, including parallel focal and arm-level events, affecting different parental alleles within individual tumours. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA
  8. 2928
    por Zhong, Lei, Liu, Jifeng, Liu, Shuo, Tan, Guang
    Publicado 2023
    “…OBJECTIVE: Pancreatic cancer is a globally frequent cause of death, which can be caused by many factors. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Correlation between pancreatic cancer and metabolic syndrome: A systematic review and meta-analysis
  9. 2929
    “…Chemotherapy is an essential postoperative treatment for pancreatic cancer, while due to the lack of effective drug evaluation platforms, the therapeutic outcomes are hampered by tumor heterogeneity among individuals. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Primary Human Pancreatic Cancer Cells Cultivation in Microfluidic Hydrogel Microcapsules for Drug Evaluation
  10. 2930
    “…BACKGROUND: There is no agreed upon standard of care for borderline‐resectable pancreatic cancer (BRPC) or locally‐advanced pancreatic cancer (LAPC) patients regarding the benefit of chemotherapy or radiation alone or in combination. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Neoadjuvant chemotherapy and radiotherapy outcomes in borderline‐resectable and locally‐advanced pancreatic cancer patients
  11. 2931
    “…BACKGROUND: An association between inflammatory bowel disease (IBD) and pancreatic cancer has been suggested in the literature. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Trends in inflammatory bowel disease and pancreatic cancer: an analysis of the National Inpatient Sample database
  12. 2932
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Involvement of clusterin expression in the refractory response of pancreatic cancer cells to a MEK inhibitor
  13. 2933
    “…This study aimed to investigate the impact on pancreatic cancer care. METHODS: All patients diagnosed with pancreatic cancer between 2017 and 2020 were selected from the Netherlands Cancer Registry. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Population-based impact of COVID-19 on incidence, treatment, and survival of patients with pancreatic cancer
  14. 2934
    “…BACKGROUND: Centralization of pancreatic cancer surgery aims to improve postoperative outcomes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Impact of network treatment in patients with resected pancreatic cancer on use and timing of chemotherapy and survival
  15. 2935
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cell-selective proteomics segregates pancreatic cancer subtypes by extracellular proteins in tumors and circulation
  16. 2936
    “…Gemcitabine (Gem) has been a standard first-line drug for pancreatic cancer (PCa) treatment; however, Gem's rapid metabolism and systemic instability (short half-life) limit its clinical outcome. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Biological evaluation of novel gemcitabine analog in patient-derived xenograft models of pancreatic cancer
  17. 2937
    “…BACKGROUND: Few studies have focused on computed tomography findings before a pancreatic cancer diagnosis. We aimed to investigate the prediagnostic computed tomography findings of patients who had undergone computed tomography within the prediagnostic period of their pancreatic cancer diagnosis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Suspicious findings observed retrospectively on CT imaging performed before the diagnosis of pancreatic cancer
  18. 2938
    “…We subsequently evaluated the ability of these epidrugs to sensitize pancreatic cancer cells to five chemotherapeutic drugs that are clinically used for this malignancy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Priming therapy by targeting enhancer-initiated pathways in patient-derived pancreatic cancer cells
  19. 2939
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Gene signature developed for predicting early relapse and survival in early-stage pancreatic cancer
  20. 2940
    por Boonhat, H, Pratama, A P, Lin, J-T, Lin, R-T
    Publicado 2023
    “…BACKGROUND: Evidence is lacking on the occupational exposure time window to chemical agents related to pancreatic cancer risk. AIMS: This study performed meta-regression and meta-analysis to examine the dose–response association between occupational exposure duration to chemical agents and pancreatic cancer risk. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Duration–response association between occupational exposure and pancreatic cancer risk: meta-analysis
Herramientas de búsqueda: RSS